Brevan Howard Capital Management’s ResMed RMD Stock Holding History

Brevan Howard Capital Management’s Portfolio RMD Stock Details RMD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$4.53M	Buy	23,225 +20,942	+917%	+$4.34M	0.03%	374
2026 Q1	$512K	Sell	2,283 -203	-8%	-$50.6K	﹤0.01%	1292
2025 Q4	$599K	Buy	+2,486	New	+$636K	0.01%	1011
2025 Q3	–	Sell	-12,160	Closed	-$3.14M	–	2226
2025 Q2	$3.14M	Buy	+12,160	New	+$2.9M	0.02%	556
2025 Q1	–	Sell	-6,726	Closed	-$1.54M	–	1411
2024 Q4	$1.54M	Buy	+6,726	New	+$1.62M	0.01%	334
2024 Q3	–	Sell	-6,111	Closed	-$1.17M	–	1391
2024 Q2	$1.17M	Buy	+6,111	New	+$1.24M	0.01%	330

Other funds holding RMD

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return

First Trust Advisors Wheaton, Illinois $170B AUM 46.21% 1-Year Est. Return

Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return

Brevan Howard Capital Management's RMD Position: Q2 2026 in Review

Brevan Howard Capital Management increased its ResMed (RMD) stake by 917% in Q2 2026, buying an estimated $4.34M and bringing the position to 23,225 shares worth $4.53M. The position accounts for 0.03% of the portfolio, ranked #374.

Brevan Howard Capital Management first reported a position in RMD in Q2 2024 and has held it in 6 quarters since. 891 funds tracked by Wall St. Rank hold RMD as of Q2 2026.

Brevan Howard Capital Management held 23,225 shares of ResMed worth $4.53M as of Q2 2026.
Brevan Howard Capital Management bought 20,942 ResMed shares in Q2 2026, an estimated $4.34M.
ResMed made up 0.03% of Brevan Howard Capital Management's portfolio in Q2 2026, its #374 holding.
Brevan Howard Capital Management first reported a position in ResMed in Q2 2024 and has held it in 6 quarters since.
891 funds tracked by Wall St. Rank held ResMed as of Q2 2026.

Based on Brevan Howard Capital Management's 13F filing for Q2 2026, filed 14 Aug 2026.